C28 - Advances in Neurogenetics

Event Time: Sunday April 23, 2017 7:00 am to 9:00 am
Topic(s): General Neurology
Director(s): Matthew Harms MD
Description: Continuing advances in genetics have led to greatly accelerated gene discovery in neurologic disorders, improving diagnosis, providing new mechanistic insights, and identifying therapeutic targets. Faculty will highlight recent technological advances and discoveries impacting the entire spectrum of neurologic diseases. In-depth focus topics will include the genetics of movement disorders and the genetics of inherited and acquired myopathies. Faculty will cover critical areas in neurogenetics, encompassing a broad spectrum of neurologic disorders that differ in their clinical manifestation, age of onset, neuroanatomical susceptibilty, and genetic mechanism. Faculty will also cover important ethical and methodological issues concerning genetic testing for neurogenetic disorders, challenges in data interpretation, and translation of neurogenetics into clinical practice.
Completion Message: Participants should obtain a broad overview of neurogenetic advances, familiarity with available tools in diagnostics, current understanding of disease mechanisms underlying hereditary developmental and degenerative neurologic disorders, treatment strategies, and expert opinions on practical and still-evolving approaches to neurogenetic disorders.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses